Sanofi's Lemtrada Improves Disability Scores in MS Patients - BusinessWeek

[**Sanofi's Lemtrada Improves **Disability** Scores in MS Patients**][1]
**BusinessWeek**
By Albertina Torsoli on April 24, 2012 Sanofi (SAN), France's largest drugmaker, said its experimental medicine Lemtrada led to an improvement in **disability** scores in patients with multiple sclerosis compared to an older treatment.

[****][2]

[1]: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF2fS_vB8gfdBne1Ecumd8wrieqIQ&url=http://www.businessweek.com/news/2012-04-24/sanofi-s-lemtrada-improves-disability-scores-in-ms-patients
[2]: http://news.google.com/news/more?gl=us&pz=1&ned=us&ncl=dGdR8VssgHcez5M

URL: http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF2fS_vB8gfdBne1Ecumd8wrieqIQ&url=http://www.businessweek.com/news/2012-04-24/sanofi-s-lemtrada-improves-disability-scores-in-ms-patients